More than a hundred years after the first pathological description of mammary and extramammary Paget's disease (Paget, 1874) , researchers still seek to clarify both of the nature of the process and the cell of origin.
Several investigators using both light and electronmicroscopical studies have proposed a variety of cell-types as the progenitors of Paget's cells, especially the extramammary variety (Ashikari et al., 1970; Demopoulos, 1970; Ferenczy & Richart, 1972; Fetherston & Friedrich, 1972; Lee et al., 1977; Mazonjian et al., 1984; Medenica and Sahihi, 1972; Orr and Parish, 1962; Roth et al., 1977; Sagebiel, 1969; Paone & Beker, 1981) . The controversy over the histogenesis of Paget's cells has diverged into two main lines of opinion, viz. (a) migration of tumour cells from an underlying carcinoma or (b) developing as an independent in situ focus of malignant transformation in the epidermis. The former hypothesis has been widely supported especially in the case of Paget's disease of the nipple associated with an underlying invasive carcinoma of the breast. However, there persists a disagreement over the direction in which tumour cells migrate. Such disagreement is particularly evident with respect to Paget's disease of extramammary sites which is not always associated with an underlying neoplasm.
In an attempt to define the histogenesis of mammary and extramammary Paget's disease, the immunohistological staining patterns of antibodies to two immunologically and structurally distinct glycoproteins purified from human milkfat-globule membrane (MFGM) were studied (Imam & Tokes, 1981; Imam et al., , 1982 . The purified glycoproteins were designated MFGM-gp 70 and MFGM-gp 155 to indicate their origin and molecular weights (Imam & Tokes, 1981; Imam et al., , 1982 Imam et al., , 1984 Imam et al., , 1986 . The patterns of distribution of these cell surface glycoproteins, the expression of which is related to cellular differentiation, shed light on the origin of neoplastic cells of Paget's disease of mammary and extramammary sites.
Purification of MFGM-gp 70 and MFGM-gp 155
Two major glycoprotein components were purified to homogeneity from human milk-fat-globule membrane as described previously (Imam et al., , 1982 . Each purified component yielded a single band under reducing conditions on SDS: polyacrylamide gel electrophoresis and has estimated molecular weights of 70,000 and 155,000 daltons (Imam et al., , 1982 . They were designated MFGM-gp 70 and MFGM-gp 155. The physiochemical properties of these glycoproteins have been described (Imam et al., 1984 and are summarized in Table I. Production of antisera to MFGM-gp 70 and MFGM-155 New Zealand white rabbits were immunized with the purified glycoprotein components, MFGM-gp 70 and MFGM-gp 155. The scheme for immunization was as described elsewhere (Imam et al., , 1982 . The isolation of immunoglobulin G from the specific antisera and preimmune rabbit serum has also been as described previously . (Imam & Taylor, 1985 (Imam et al., 1984 . A brief description of their physiochemical properties is summarized in Table 1 . The ability of these glycoproteins to retain their antigenic sites from denaturing, in formalin-fixed and paraffin-embedded tissue sections, has facilitated the study of their distributions by immunohistochemical methods under these conditions.
Antibodies to MFGM-gp 70
The binding characteristics of rabbit antiserum to MFGMgp 70 to cells in normal mammary gland and skin are summarized in Table II . In normal breast, antibodies to MFGM-gp 70 reacted strongly with the luminal membrane of epithelial cells lining the ducts (Figure la) and lobules (not shown). In infiltrating ductal and lobular carcinomas of breast, the patterns of reactivity were markedly different, as shown by the presence of staining distributed both on the membrane and in cytoplasm, depending upon the morphological differentiation of the tumour cells (Imam et al., 1984 Mammary and extramammary Paget's cells are now generally accepted to represent intraepidermal carcinoma cells of glandular differentiation which are usually, but not always, associated with an in situ or infiltrating adenocarcinoma within the underlying ducts or adnexal structures. Supportive immunohistochemical evidence for the glandular nature of Paget's cells comes from Bussolati and Pich (1975) who have demonstrated the presence of casein in mammary and extramammary Paget cells, and from several studies demonstrating immunoreactivity of mammary and extramammary Pagets cells with cytokeratin antibodies that selectively react with glandular epithelial cells (Kariniemi et al., 1985 , Hamm & Vroon, 1986 & Ordonez et al., 1987 . In addition, Nadji et al., (1982) have shown similar patterns of immunoreactivity for carcinoembryonic antigen (CEA) within mammary and extramammary Paget's cells, and Mazoujian et al. (1984) demonstrated immunoperoxidase localization of GCDFP-15 in extramammary Paget cells in some cases. More recently, Kariniemi et al. (1984) , Kirkham et al. (1985) and Vanstapel et al. (1984) have demonstrated the expression of antigens recognized by their own antibodies to human milk-fatglobule membrane in tumour cells of both mammary and extramammary Paget's diseases.
In the present study, polyclonal antibodies to two immunologically distinct glycoproteins purified from human milkfat-globule membrane (MFGM) (Imam et al., , 1982 were used to study the specificity and patterns of reactivity in tumour cells of mammary and extramammary Paget's disease. These glycoproteins are immunologically and biochemically distinct from each other and are unrelated to milk whey proteins, serum proteins, blood group antigens, lymphocyte antigens, keratins, carcinoembryonic antigen and mouse mammary tumour virus glycoproteins (Imam et al., , 1982 .
The finding of reactivity of antibodies against MFGM-gp 70 to Paget's cells of both mammary and extramammary Paget's disease confirms previous studies that Paget's cells show differentiation features in common with glandular epithelium (Table III) . Furthermore, MFGM-gp 70 and MFGM-gp 155 positivity in the tumour cells of mammary Paget's disease demonstrates the phenotypic similarity between mammary Paget's cells and underlying mammary carcinoma, since both MFGM-gp 70 and MFGM-gp 155 are also commonly present in normal breast and mammary carcinoma cells (Tables II-IV) .
Interestingly, while 7 of 8 cases of mammary Paget's disease expressed MFGM-gp 155, all 8 cases of extramammary Paget's disease were nonreactive for the antigen under the conditions employed in this study. The possibility that formalin-fixation may alter MFGM-gp 155 configuration in extramammary Paget's cells in tissue reactions, leading to the negative staining seems unlikely as tissues other than breast fixed under the same conditions showed consistently strong reactivity with the antibodies to MFGMgp 155 (Ordonez et al., 1987 Nipple  3+  85  Vulva  2+  75  2  Nipple  2+  60  Vulva  3+  60  3  Nipple  2+  90  Vulva  -0  4  Nipple  2+  75  Leg  -0  5  Nipple  2+  60  Anus  1+  60  6  Nipple  3+  60  Anus  2+  80  7  Nipple  2+  90  Groin  1+  75  8  Nipple  3+  60  Groin  1+  80 aSections were recorded for the intensity of staining on scale from -to 3+. Absence of staining: -; weak staining: 1 +; moderate staining: 2 +; intense staining: 3 +. (Mazoujian et al., 1984) . However, GCDFP-15, initially reported to be localized within apocrine but not eccrine glands, has subsequently been shown to be expressed by both apocrine as well as eccrine glands (Ordonez et al., 1987) . Our findings of MFGM-gp 70 in apocrine glandular epithelium and the lack thereof in eccrine glandular epithelium provide evidence that MFGM-gp 70 may function as a presumptive marker of apocrine differentiation. Therefore, the finding that extramammary Paget's cells, in the majority of cases of extramammary Paget's disease, express MFGM-gp 70 immunoreactivity suggests that extramammary Paget's cells derive from or differentiate along the line of apocrine glandular epithelium. The lack of MFGM-gp 155 expression by extramammary Paget's cells provides supportive evidence because apocrine, as well as eccrine, glands also lack MFGM-gp 155 expression. However, we cannot entirely rule out the possibility that the two cases of extramammary Paget's disease negative for MFGM-gp 70 are of eccrine derivation. Isolated case reports suggest that such an eccrine line of differentiation may occur in a few cases (de Blois et al., 1984) .
In summary, the expression of MFGM-gp 155 is quite specific in its localization to breast lobules and terminal ducts and is not found in apocrine and eccrine glandular, and squamous epithelial cells; it is expressed in mammary Paget's cells but not in Paget' 
